Cargando…

TORward a Molecular Convergence Point in Pulmonary Arterial Hypertension With mTOR

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Maron, Bradley A., Wilkins, Martin R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315047/ https://www.ncbi.nlm.nih.gov/pubmed/30623135 http://dx.doi.org/10.1016/j.jacbts.2018.08.003

Ejemplares similares

Clarifying the Pulmonary Arterial Hypertension Molecular Landscape Using Functional Genetics
por: Maron, Bradley A.
Publicado: (2020)

Clinical trials of mTOR inhibitors to boost immunity to viral infection in older adults
por: Dzankic, Paula Juricic, et al.
Publicado: (2021)

Quality of life in pulmonary arterial hypertension
por: Post, M.C., et al.
Publicado: (2015)

Evaluation of pulmonary arterial hypertension: invasive or noninvasive?
por: van der Laarse, A., et al.
Publicado: (2010)

AMPK/Ulk1-dependent autophagy as a key mTOR regulator in the context of cell pluripotency
por: Suvorova, Irina I., et al.
Publicado: (2019)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

mTOR in cerebrovascular disease
por: Van Skike, Candice E., et al.
Publicado: (2019)

mTOR in Human Diseases
por: Dormond, Olivier
Publicado: (2019)

mTOR Signaling in Metabolism and Cancer
por: Huang, Shile
Publicado: (2020)

Targeting Neurohormonal Activation in Pulmonary Arterial Hypertension: Putting the Puzzle Together
por: Gomez-Arroyo, Jose, et al.
Publicado: (2017)

Pulmonary arterial hypertension: Cellular and molecular changes in the lung
por: Maron, Bradley A.
Publicado: (2020)

Ion channels as convergence points in the pathology of pulmonary arterial hypertension
por: Jouen-Tachoire, Thibault R. H., et al.
Publicado: (2021)

The Importance of Echocardiographic Screening for Pulmonary Arterial Hypertension in Korean Patients with Systemic Sclerosis
por: Kim, Hack-Lyoung
Publicado: (2016)

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
por: Leopold, Jane A., et al.
Publicado: (2016)

Exploiting the mTOR paradox for disease prevention
por: Iglesias-Bartolome, Ramiro, et al.
Publicado: (2012)

EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)

Age-related mTOR in gynaecological cancers
por: Bajwa, Preety, et al.
Publicado: (2017)

Revisiting mTOR and Epithelial–Mesenchymal Transition
por: Herrerias, Mariana M., et al.
Publicado: (2020)

ROS, Klotho and mTOR in cardiorenal aging
por: Daneshgar, Nastaran, et al.
Publicado: (2020)

Introducing the Pulmonary Hypertension Thematic Series
por: Maron, Bradley A.
Publicado: (2023)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
por: Murray, James T., et al.
Publicado: (2018)

mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging
por: Das, Anindita, et al.
Publicado: (2017)

mTOR pathway in familial focal epilepsies
por: Ribierre, Théo, et al.
Publicado: (2016)

microRNAs calibrate T cell responses by regulating mTOR
por: Merkenschlager, Matthias, et al.
Publicado: (2015)

mTOR: Alzheimer's disease prevention for APOE4 carriers
por: Lin, Ai-Ling, et al.
Publicado: (2016)

VEGF-mTOR signaling links obesity and endometrial cancer
por: Sahoo, Subhransu S., et al.
Publicado: (2018)

mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging 2018
por: Das, Anindita, et al.
Publicado: (2019)

mTOR Signaling Network in Cell Biology and Human Disease
por: Yu, Jane J., et al.
Publicado: (2022)

The mTOR pathway genes mTOR, Rheb, Depdc5, Pten, and Tsc1 have convergent and divergent impacts on cortical neuron development and function
por: Nguyen, Lena H., et al.
Publicado: (2023)

GCN2 and TOR converge on aging
por: Vlanti, Anna, et al.
Publicado: (2013)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Molecular mechanisms of mTOR regulation by stress
por: Heberle, Alexander Martin, et al.
Publicado: (2014)

IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma
por: Folgiero, Valentina, et al.
Publicado: (2016)

STAT3 and mTOR: co-operating to drive HIF and angiogenesis
por: Dodd, Kayleigh M., et al.
Publicado: (2015)

Editorial Comment on the articles of W. Mądry and M.A. Karolczak Totally anomalous pulmonary venous drainage – supracardiac type: ultrasound assessment of anatomically determined stenosis of the vertical vein collecting pulmonary venous return and Ultrasound diagnosis of pulmonary sling with proximal stenosis of left pulmonary artery and patent arterial duct
por: Respondek-Liberska, Maria
Publicado: (2013)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

mTOR pathway activation in age-related retinal disease
por: Zhao, Chen, et al.
Publicado: (2011)

Vagal Nerve Stimulation for Pulmonary Hypertension: Some Promise, Some Skepticism
por: Ntokou, Aglaia, et al.
Publicado: (2018)

Point mutations of the mTOR-RHEB pathway in renal cell carcinoma
por: Ghosh, Arindam P., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ca4trgv3dhtp67vk4nmstsku5v